Catalyst Wire Dossier Catalyst Wire Dossier

ProSavin

· Oxford BioMedica
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ProSavin, covering 2013-05-13 to 2013-05-13. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Study of the Safety, Efficacy and Dose Evaluation of ProSavin for the Treatment of Bilateral Idiopathic Parkinson's Disease [Phase 1, Phase 2]

See pricing